Amgen Inc. (NASDAQ: AMGN) is a large market cap stock with a market cap of 129149.47. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 17.6, a forward P/E of 13.78 and EPS of 9.77. At a stock price of 171.97 (1.02%) it has a dividend yield of 2.33%.
EPS growth for the last five years have been 13.60%, more recently this last year it has grown by 35.20%. The next year growth is going to be about 9.84% and more long-term 8.48% after five years. EPS growth quarter over quarter is 14.90%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is 5.90%.
For performance, Amgen Inc. the past week has seen a gain of -0.95%. For the last month performance for Amgen Inc. is 0.99%. While the last quarter is 10.35% and half year, 22.37%. Finally for the year, performance is 13.16%.
The 52-week high for Amgen Inc., is at -2.64%, and for the 52-week low it comes to a value of 35.45%. The 20-day simple moving average is 5.46% and 11.13% for the 200-day simple moving average.
Volatility for the week is at 1.73%, and for the month it is 1.46%. Amgen Inc., has a target price of 191.
In terms of debt, long term debt/equity is 0.93, and for total debt/equity Amgen Inc. has 1.1. The gross margin is 81.40%, while operating margin is 40.70%, the profit margin is 33.10%. The current ratio is 4 and the quick ratio is 3.7.
Insider ownership is at 0.20%, with instituitional ownership at 81.20%. Amgen Inc. has a payout ratio of 36.30%. With the total shares outstanding coming to 751. The shares float is 747.47, with the float short at 1.08%, with short ratio coming to 2.81.
In terms of returns, the return on assets see Amgen Inc., get 10.10%, with its returns on investment at 12.50%. Return on equity is 25.90%. So will the investors see the target price of 191, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.